Celladon Corporation (CLDN) Downtrend Brings Out Bears

Traders are on edge ahead of trial results from Celladon Corporation (CLDN)

Digital Content Group
Apr 20, 2015 at 2:38 PM
facebook X logo linkedin


Celladon Corporation (NASDAQ:CLDN) is among a number of health care stocks getting whacked today -- down 4% at $15.86 ahead of crucial results from its Mydicar gene therapy trial, due out sometime this month. In the equity's options pits, puts are running at more than twice their usual intraday rate. Also, CLDN's 30-day at-the-money implied volatility earlier touched an annual high of 418.6%, hinting at heightened anxiety levels ahead of the aforementioned data.

The most active put this afternoon is the May 17.50 strike, where likely buy-to-open activity is transpiring. Based on the volume-weighted average price (VWAP) of $7.97, the buyers are aiming for CLDN to plummet below $9.53 (strike less VWAP) by May options expiration. This would put the stock in waters not charted since mid-October.

Today's penchant for put buying is par for the course. During the past 10 days across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), CLDN has racked up a put/call volume ratio of 3.43 -- with puts bought to open at more than three times the rate of calls.

Short sellers have been extremely active of late, too. During the two most recent reporting periods, short interest on CLDN nearly tripled, and now makes up 23% of its total float -- though it would take less than two days to cover these positions, at average daily trading levels.

On the charts, Celladon Corporation's (NASDAQ:CLDN) intraday losses are pretty typical. Since notching a record high of $28.25 on March 20, the stock has plunged an astounding 44%, and underperformed the broader S&P 500 Index (SPX) by about 36 percentage points.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI